Opthea Investigational Site

Reno, Nevada 89502

We've found

1 trials

at this facility

A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Reno, NV

Use our guide to learn which trials are right for you!